Zhitong Finance App News, Chuangmei Pharmaceutical (02289) announced that the replacement of the company's authorized representative under section 3.06 (2) of the Hong Kong Stock Exchange Limited Securities Listing Rules and the authorized representative of the company under Part 16 of the Companies Ordinance, Chapter 622 of the Hong Kong Laws, has been confirmed to have passed away on October 28, 2026.

Following the death of Ms. Lam, the board of directors also announced that Mr. Bo Wen, the current senior head of the listed company secretariat of Fangyuan Enterprise Service Group (Hong Kong) Limited, has been appointed as a replacement for the authorized representative of the company under section 3.06 (2) of the Listing Rules and the authorized representative of the company under Part 16 of the Companies Regulations, with effect from November 9, 2026.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.